Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages JCO.21.00471
Publisher
American Society of Clinical Oncology (ASCO)
Online
2021-05-04
DOI
10.1200/jco.21.00471
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events
- (2020) Alessio Cortellini et al. EUROPEAN JOURNAL OF CANCER
- The justification of vincristine dose capping: tradition, tradition…tradition!
- (2020) Nancy L. Bartlett LEUKEMIA & LYMPHOMA
- The Effects of Obesity on Anti-Cancer Immunity and Cancer Immunotherapy
- (2020) Matthew J. Woodall et al. Cancers
- Cancer Disparities and Health Equity: A Policy Statement From the American Society of Clinical Oncology
- (2020) Manali I. Patel et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk
- (2020) Barbara Pistilli et al. JOURNAL OF CLINICAL ONCOLOGY
- Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms
- (2020) Christine M. Friedenreich et al. Molecular Oncology
- Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non-small cell lung cancer harboring an EGFR mutation: A prospective observational study
- (2019) Taihei Ono et al. Thoracic Cancer
- The prognostic role of obesity is independent of sex in cancer patients treated with immune checkpoint inhibitors: A pooled analysis of 4090 cancer patients
- (2019) Huilin Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218
- (2019) K.N. Slaughter Wade et al. GYNECOLOGIC ONCOLOGY
- Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study
- (2019) Elisé G. Kaboré et al. PLOS MEDICINE
- Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer
- (2019) Ganessan Kichenadasse et al. JAMA Oncology
- Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer
- (2019) Elizabeth M. Cespedes Feliciano et al. JAMA Oncology
- Safety and dose modification for patients receiving niraparib
- (2018) J S Berek et al. ANNALS OF ONCOLOGY
- Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials
- (2018) Thomas Aparicio et al. EUROPEAN JOURNAL OF CANCER
- Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study
- (2018) Gertraud Stocker et al. EUROPEAN JOURNAL OF CANCER
- Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
- (2018) Jennifer L McQuade et al. LANCET ONCOLOGY
- Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study
- (2018) Kyung Hae Jung et al. ONCOLOGIST
- The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436)
- (2018) Vicki A. Morrison et al. Journal of Geriatric Oncology
- Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer
- (2018) G V Long et al. ANNALS OF ONCOLOGY
- Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent
- (2018) James K. R. Stevenson et al. LEUKEMIA & LYMPHOMA
- Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline
- (2017) Timothy Gilligan et al. JOURNAL OF CLINICAL ONCOLOGY
- Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2017) Betty R. Ferrell et al. JOURNAL OF CLINICAL ONCOLOGY
- Fixed Dosing of Monoclonal Antibodies in Oncology
- (2017) Jeroen J.M.A. Hendrikx et al. ONCOLOGIST
- Association between obesity and trastuzumab-related cardiac toxicity in elderly patients with breast cancer
- (2017) Hai-Yan Wang et al. Oncotarget
- Evaluation of dosing strategy for pembrolizumab for oncology indications
- (2017) Tomoko Freshwater et al. Journal for ImmunoTherapy of Cancer
- Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study
- (2016) J. Furlanetto et al. ANNALS OF ONCOLOGY
- Is rituximab sub-optimally dosed in indolent B cell lymphoma?
- (2016) Yazeed Sawalha et al. BRITISH JOURNAL OF HAEMATOLOGY
- Myelosuppression by chemotherapy in obese patients with gynecological cancers
- (2016) Kensuke Kamimura et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Effect of Body Mass Index– and Actual Weight–Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer
- (2016) Rachna Raman et al. Clinical Breast Cancer
- Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy
- (2016) Shlomit Strulov Shachar et al. CLINICAL CANCER RESEARCH
- Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients
- (2016) Poorna Anandavadivelan et al. CLINICAL NUTRITION
- Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer
- (2016) H. Lote et al. CLINICAL ONCOLOGY
- Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database
- (2016) Lindsay A. Renfro et al. JOURNAL OF CLINICAL ONCOLOGY
- Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities
- (2016) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
- (2016) Charles Guenancia et al. JOURNAL OF CLINICAL ONCOLOGY
- Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
- (2016) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Obese non-Hodgkin lymphoma patients tolerate full uncapped doses of chemotherapy with no increase in toxicity, and a similar survival to that seen in nonobese patients
- (2016) Henry Chan et al. LEUKEMIA & LYMPHOMA
- Individual 5-Fluorouracil Dose Adjustment via Pharmacokinetic Monitoring Versus Conventional Body-Area-Surface Method
- (2016) Runfeng Yang et al. THERAPEUTIC DRUG MONITORING
- Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens
- (2016) Raafi Ali et al. Cancer Medicine
- Comparison of two different formulas for body surface area in adults at extremes of height and weight
- (2016) Karen M Fancher et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
- (2016) Paul Kotwinski et al. PLoS One
- Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage
- (2015) Hwa Jung Sung et al. ACTA HAEMATOLOGICA
- Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy
- (2015) Suzanne Tavitian et al. AMERICAN JOURNAL OF HEMATOLOGY
- Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials
- (2015) Caterina Fontanella et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of body surface area on survival in EGFR-mutant non-small cell lung cancer patients treated with gefitinib monotherapy: observational study of the Okayama Lung Cancer Study Group 0703
- (2015) Kenichiro Kudo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight
- (2015) Whitney M. Bray et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer
- (2015) B.H.L. Tan et al. EJSO
- A high BMI is a risk factor in younger patients withde novoacute myelogenous leukemia
- (2015) Martina Crysandt et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients
- (2015) Jean Hansen et al. GYNECOLOGIC ONCOLOGY
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
- (2015) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Tolerability of induction chemotherapy dosing practices in acute myeloid leukemia patients
- (2015) Kaylene M. Peric et al. LEUKEMIA RESEARCH
- Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer
- (2015) Bjørg Sjøblom et al. LUNG CANCER
- Impact of weight bias and stigma on quality of care and outcomes for patients with obesity
- (2015) S. M. Phelan et al. Obesity Reviews
- Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index
- (2015) Elisa V. Bandera et al. JAMA Oncology
- Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review
- (2015) Weixin Wu et al. PLoS One
- The role of body mass index in survival outcome for lymphoma patients: US intergroup experience
- (2014) F. Hong et al. ANNALS OF ONCOLOGY
- Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone
- (2014) Arun Ganti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutation
- (2014) Satoshi Igawa et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer
- (2014) Katrina N. Slaughter et al. GYNECOLOGIC ONCOLOGY
- Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS)
- (2014) George Au-Yeung et al. GYNECOLOGIC ONCOLOGY
- Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia
- (2014) Emmanuelle Kempf et al. LEUKEMIA RESEARCH
- Toxicity and tolerability of adjuvant breast cancer chemotherapy in obese women
- (2014) James P. Carroll et al. MEDICAL ONCOLOGY
- Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer
- (2014) Maximilien Barret et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight
- (2013) Candice M. Wenzell et al. AMERICAN JOURNAL OF HEMATOLOGY
- Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia
- (2013) Andrew M. Brunner et al. AMERICAN JOURNAL OF HEMATOLOGY
- Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis
- (2013) K. C. Hourdequin et al. ANNALS OF ONCOLOGY
- Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma
- (2013) L. Weiss et al. ANNALS OF ONCOLOGY
- Suboptimal dosing of rituximab in male and female patients with DLBCL
- (2013) M. Pfreundschuh et al. BLOOD
- Adipokines: A link between obesity and cardiovascular disease
- (2013) Kazuto Nakamura et al. Journal of Cardiology
- Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
- (2013) Stacie B. Dusetzina et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations
- (2013) Eiki Ichihara et al. LUNG CANCER
- Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients
- (2012) T. Miyahara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer
- (2012) Rabbie K. Hanna et al. GYNECOLOGIC ONCOLOGY
- Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia
- (2012) B. C. Medeiros et al. HAEMATOLOGICA
- Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2012) Jennifer J. Griggs et al. JOURNAL OF CLINICAL ONCOLOGY
- Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia
- (2012) Andrew Lin et al. LEUKEMIA & LYMPHOMA
- Is obesity a prognostic factor for acute myeloid leukemia outcome?
- (2011) Hun Ju Lee et al. ANNALS OF HEMATOLOGY
- Chemotherapy dose reductions in obese patients with colorectal cancer
- (2011) P. Chambers et al. ANNALS OF ONCOLOGY
- Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy
- (2011) Lieke H.J. Simkens et al. EUROPEAN JOURNAL OF CANCER
- Building better guidelines with BRIDGE-Wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability
- (2011) Richard N Shiffman et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Evaluation of Chemotherapy-Induced Severe Myelosuppression Incidence in Obese Patients With Capped Dosing
- (2011) Monique D. Lopes-Serrao et al. Journal of Oncology Practice
- Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions
- (2011) Sonya Blesser Streeter et al. Journal of Oncology Practice
- American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
- (2009) Neal J. Meropol et al. JOURNAL OF CLINICAL ONCOLOGY
- The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering
- (2008) Rachel P. Wildman ARCHIVES OF INTERNAL MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started